Search Results

You are looking at 1 - 3 of 3 items for :

  • "hematopoietic stem cell transplantation" x
Clear All
Open access

Luminita Nicoleta Cima, Anca Colita and Simona Fica

Introduction Hematopoietic stem cell transplantation (HSCT) is increasingly used for the treatment of both malignant and nonmalignant diseases. Survival after autologous/allogeneic HSCT is no longer the highest concern, as many patients

Open access

Sandrine Visentin, Gérard Michel, Claire Oudin, Béatrice Cousin, Bénédicte Gaborit, Inès Abdesselam, Marie Maraninchi, Marion Nowicki, René Valéro, Maxime Guye, Monique Bernard, Pascal Auquier, Hervé Chambost, Marie-Christine Alessi and Sophie Béliard

before hematopoietic stem-cell transplantation, represents a major risk factor for developing MS and CVD ( 10 , 11 , 12 , 13 , 14 , 15 ). In the LEA cohort, MS was found in 18.9% of young adults (mean age 21 years) who had received TBI during

Open access

Paal Methlie, Steinar Hustad, Ralf Kellman, Bjørg Almås, Martina M Erichsen, Eystein S Husebye and Kristian Løvås

(LC–MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients . Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 885–886 2012 131 – 137 . ( doi:10.1016/j.jchromb.2011